Spero Therapeutics Total Assets (Quarterly) Trends

Spero Therapeutics Inc (SPRO)

1.175 -0.02 (-1.26%) USD | NASDAQ | Nov 22, 16:00

1.175 0.00 (0.00%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
September 30, 2024	135.16M
June 30, 2024	149.88M
March 31, 2024	167.70M
December 31, 2023	182.39M
September 30, 2023	107.10M
June 30, 2023	98.88M
March 31, 2023	112.55M
December 31, 2022	124.80M
September 30, 2022	64.48M
June 30, 2022	63.63M
March 31, 2022	145.83M
December 31, 2021	171.07M
September 30, 2021	144.69M
June 30, 2021	119.59M
March 31, 2021	143.44M
December 31, 2020	153.45M

Date	Value
September 30, 2020	157.04M
June 30, 2020	97.54M
March 31, 2020	109.89M
December 31, 2019	106.10M
September 30, 2019	112.51M
June 30, 2019	122.49M
March 31, 2019	124.65M
December 31, 2018	129.01M
September 30, 2018	136.12M
June 30, 2018	72.59M
March 31, 2018	81.06M
December 31, 2017	93.48M
September 30, 2017	31.55M
June 30, 2017	40.10M
December 31, 2016	13.77M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

63.63M

Minimum

Jun 2022

182.39M

Maximum

Dec 2023

127.76M

Average

129.98M

Median

Total Assets (Quarterly) Benchmarks

CytomX Therapeutics Inc	138.98M
Johnson & Johnson	178.29B
Arbutus Biopharma Corp	140.44M
Equillium Inc	34.46M
NovaBay Pharmaceuticals Inc	3.877M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	69.65M
Shareholders Equity (Quarterly)	65.51M
Current Ratio	2.681